Aims and scope of journal
Journal of Human Hypertension is published monthly and is of interest to health care professionals who deal with hypertension (specialists, internists, primary care physicians) and public health workers. We believe that our patients benefit from robust scientific data that are based on well conducted clinical trials. We also believe that basic sciences are the foundations on which we build our knowledge of clinical conditions and their management. Towards this end, although we are primarily a clinical based journal, we also welcome suitable basic sciences studies that promote our understanding of human hypertension.
The journal aims to perform the dual role of increasing knowledge in the field of high blood pressure as well as improving the standard of care of patients. The editors will consider for publication all suitable papers dealing directly or indirectly with clinical aspects of hypertension, including but not limited to epidemiology, pathophysiology, therapeutics and basic sciences involving human subjects or tissues. We also consider papers from all specialties such as ophthalmology, cardiology, nephrology, obstetrics and stroke medicine that deal with the various aspects of hypertension and its complications.
Journal of Human Hypertension covers a range of subject areas, to read content across the scope of the journal view the journal's subjects page here.
12 issues per year
Our publishing models
Journal of Human Hypertension is a Transformative Journal (TJ). When research is accepted for publication, authors can choose to publish using either the traditional publishing route OR via immediate gold Open Access.
Journal of Human Hypertension is actively committed to becoming a fully Open Access journal. We will increase the number of articles we publish OA, with the eventual goal of becoming a fully Open Access journal. A journal that commits to this process is known as a Transformative Journal.
Authors may need to take specific actions to achieve compliance with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route our standard licensing terms will need to be accepted including our self-archiving policies. Those standard licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.
Article metrics such as number of downloads, citations and online attention are available from each article page, and provide an overview of the attention received by a paper.
The 2020 peer review performance metrics for Journal of Human Hypertension are shown below:
Average time to decision without external review - 15 days
Average time to decision following external review - 60 days
Average time from submission to acceptance - 138 days
Average time from acceptance to publication - 14 days
Article page views - 838,416
Altmetric mentions - 1,350
The 2020 journal metrics* for Journal of Human Hypertension are as follows:
2-year Impact Factor*: 3.012
5-year Impact Factor*: 2.879
Immediacy index*: 0.822
Eigenfactor® score*: 0.00406
Article influence score*: 0.733
JCR Rank*: 33/65 Peripheral Vascular Disease
Journal Citation Score*: 0.57
*2020 Journal Citation Reports® Science Edition (Clarivate Analytics, 2020)
EBSO Discovery Service
Current Contents/Clinical Medicine
Science Citation Index Expanded (SciSearch)
EBSCO Academic Search
EBSCO Advanced Placement Source
EBSCO Biomedical Reference Collection
EBSCO Food Science Source
EBSCO STM Source
EBSCO TOC Premier
ISSN and eISSN
International standard serial number (ISSN): 0950-9240
Electronic international standard serial number (eISSN): 1476-5527.
Journal of Human Hypertension now provides its latest table of contents as an RSS web feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.